ConductScience.org, home

Paper1502017

Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (delta 2(E)-valproate) in healthy male volunteers.

Düsing RH. Pharm Weekbl Sci, 1992. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (delta 2(E)-valproate) in healthy male volunteers. Papers, record 1502017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1502017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (delta 2(E)-valproate) in healthy male volunteers.
PubMed
Journal
Pharm Weekbl Sci
PubMed
Year
1992
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.82
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Düsing RHR H

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticonvulsantsMajor topic
Fatty Acids, MonounsaturatedMajor topic
Adult
Drug Tolerance
Humans
Male

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in1502018Studies on 2-n-propyl-2(E)-pentenoate (delta 2(E)-valproate) in man.https://conductscience.org/library/papers/1502018

Source PubMed

Download CSV of comments and corrections

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16439041The fetal valproate syndrome.Am J Med Genet1984https://conductscience.org/library/papers/6439041PubMed
22492646Valproic acid hepatic fatalities. II. US experience since 1984.Neurology1989https://conductscience.org/library/papers/2492646PubMed
36799722
A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations.
Life Sci1981https://conductscience.org/library/papers/6799722PubMed
42931939Valproate: an updated review.Acta Neurol Scand1985https://conductscience.org/library/papers/2931939PubMed
53137017Fatal liver failure in 16 children with valproate therapy.Epilepsia1988https://conductscience.org/library/papers/3137017PubMed
63086531Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.J Pediatr1986https://conductscience.org/library/papers/3086531PubMed
76798485Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings.Neuropharmacology1981https://conductscience.org/library/papers/6798485PubMed
83146224Side effects of valproate.Am J Med1988https://conductscience.org/library/papers/3146224PubMed
93102998Valproic acid hepatic fatalities: a retrospective review.Neurology1987https://conductscience.org/library/papers/3102998PubMed
103125743Verification of the fetal valproate syndrome phenotype.Am J Med Genet1988https://conductscience.org/library/papers/3125743PubMed
112859407Comparison of the pharmacological and biochemical profiles of valproic acid (VPA) and its cerebral metabolite (2-en-VPA) after oral administration in mice.Methods Find Exp Clin Pharmacol1985https://conductscience.org/library/papers/2859407PubMed
126415511Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures.Neurology1983https://conductscience.org/library/papers/6415511PubMed
136428923Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy.Eur J Pharmacol1984https://conductscience.org/library/papers/6428923PubMed
146782218Possible teratogenicity of valproic acid.J Pediatr1981https://conductscience.org/library/papers/6782218PubMed
153114906Teratogen update: valproic acid.Teratology1987https://conductscience.org/library/papers/3114906PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
40752061Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a review.J Pharmacol Exp Ther2025https://conductscience.org/library/papers/40752061PubMed
35011339Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.Molecules2021https://conductscience.org/library/papers/35011339PubMed
28861484Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.Cannabis Cannabinoid Res2016https://conductscience.org/library/papers/28861484PubMed
8156045Can we develop improved derivatives of valproic acid?Pharm World Sci1994https://conductscience.org/library/papers/8156045PubMed
1502018Studies on 2-n-propyl-2(E)-pentenoate (delta 2(E)-valproate) in man.Pharm Weekbl Sci1992https://conductscience.org/library/papers/1502018PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1502017

GET https://conductscience.org/api/papers/v1/1502017/authors